U.S. FDA Issues Official Action Indicated Notice to Aurobindo Pharma’s Formulation Unit, Signaling Compliance Concerns
The U.S. Food and Drug Administration has classified Aurobindo Pharma Limited’s formulation manufacturing unit under the “Official Action Indicated” (OAI) category, a regulatory designation that…